Log in
NASDAQ:TRUP

Trupanion Stock Forecast, Price & News

$74.90
+0.67 (+0.90 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$73.40
Now: $74.90
$76.53
50-Day Range
$66.43
MA: $78.06
$93.30
52-Week Range
$21.86
Now: $74.90
$95.53
Volume403,884 shs
Average Volume474,828 shs
Market Capitalization$2.64 billion
P/E Ratio1,498.30
Dividend YieldN/A
Beta1.54
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Read More
Trupanion logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.31 out of 5 stars

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryN/A
SectorFinance
Current SymbolNASDAQ:TRUP
CUSIPN/A
Phone855-727-9079
Employees738

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$383.94 million
Cash Flow$0.09 per share
Book Value$3.91 per share

Profitability

Net Income$-1,810,000.00

Miscellaneous

Market Cap$2.64 billion
Next Earnings Date10/29/2020 (Confirmed)
OptionableOptionable
$74.90
+0.67 (+0.90 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TRUP News and Ratings via Email

Sign-up to receive the latest news and ratings for TRUP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Trupanion (NASDAQ:TRUP) Frequently Asked Questions

How has Trupanion's stock price been impacted by COVID-19 (Coronavirus)?

Trupanion's stock was trading at $26.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TRUP shares have increased by 187.6% and is now trading at $74.90.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Trupanion?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Trupanion
.

When is Trupanion's next earnings date?

Trupanion is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Trupanion
.

How can I listen to Trupanion's earnings call?

Trupanion will be holding an earnings conference call on Thursday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Trupanion's earnings last quarter?

Trupanion, Inc. (NASDAQ:TRUP) issued its quarterly earnings data on Tuesday, August, 4th. The financial services provider reported $0.04 EPS for the quarter, topping the Zacks' consensus estimate of ($0.01) by $0.05. The financial services provider earned $117.92 million during the quarter, compared to analysts' expectations of $114.63 million. Trupanion had a return on equity of 1.19% and a net margin of 0.38%. The company's revenue was up 27.9% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.06) EPS.
View Trupanion's earnings history
.

What price target have analysts set for TRUP?

7 analysts have issued 12 month price objectives for Trupanion's stock. Their forecasts range from $36.00 to $67.00. On average, they anticipate Trupanion's stock price to reach $49.67 in the next year. This suggests that the stock has a possible downside of 33.7%.
View analysts' price targets for Trupanion
.

Who are some of Trupanion's key competitors?

What other stocks do shareholders of Trupanion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), Micron Technology (MU), Chipotle Mexican Grill (CMG), McEwen Mining (MUX), Pfizer (PFE), Splunk (SPLK), AbbVie (ABBV), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

Who are Trupanion's key executives?

Trupanion's management team includes the following people:
  • Mr. Darryl Graham Andrew Rawlings, Founder, Pres, CEO & Director (Age 51, Pay $334.65k)
  • Ms. Tricia Lynn Plouf, Chief Financial Officer (Age 41, Pay $238.34k)
  • Mr. Gavin Derek Friedman, Chief People Officer & Gen. Counsel (Age 52, Pay $238.58k)
  • Mr. Asher Benjamin Bearman, Chief Strategy Officer & Corp. Sec. (Age 42, Pay $271.51k)
  • Ms. Margaret Tooth, Chief Revenue Officer (Age 41, Pay $266.19k)
  • Mr. Howard Elliot Rubin, Independent Director & Consultant (Age 67, Pay $112.5k)
  • Mr. Chris Cappelletti, Chief Technology Officer
  • Ms. Laura Bainbridge, Head of Corp. Communications
  • Scott Janzen, Director of Communications
  • Dr. Steve Weinrauch BVMS, MRCVS, Chief Veterinary & Chief Product Officer

What is Trupanion's stock symbol?

Trupanion trades on the NASDAQ under the ticker symbol "TRUP."

Who are Trupanion's major shareholders?

Trupanion's stock is owned by a variety of retail and institutional investors. Top institutional investors include Investmentaktiengesellschaft Fuer Langfristige Investoren TGV (1.98%), Ingalls & Snyder LLC (0.26%), Thomas Story & Son LLC (0.13%), State of Alaska Department of Revenue (0.09%), Hamilton Lane Advisors LLC (0.06%) and Louisiana State Employees Retirement System (0.04%). Company insiders that own Trupanion stock include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Murray B Low, Robin A Ferracone and Tricia Plouf.
View institutional ownership trends for Trupanion
.

Which institutional investors are selling Trupanion stock?

TRUP stock was sold by a variety of institutional investors in the last quarter, including Investmentaktiengesellschaft Fuer Langfristige Investoren TGV, Thomas Story & Son LLC, and First Hawaiian Bank. Company insiders that have sold Trupanion company stock in the last year include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Margaret Tooth, Murray B Low, Robin A Ferracone, and Tricia Plouf.
View insider buying and selling activity for Trupanion
.

Which institutional investors are buying Trupanion stock?

TRUP stock was bought by a variety of institutional investors in the last quarter, including Ingalls & Snyder LLC, State of Alaska Department of Revenue, Louisiana State Employees Retirement System, Hamilton Lane Advisors LLC, Crossmark Global Holdings Inc., Beaumont Asset Management L.L.C., and Nisa Investment Advisors LLC.
View insider buying and selling activity for Trupanion
.

How do I buy shares of Trupanion?

Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Trupanion's stock price today?

One share of TRUP stock can currently be purchased for approximately $74.90.

How big of a company is Trupanion?

Trupanion has a market capitalization of $2.64 billion and generates $383.94 million in revenue each year. The financial services provider earns $-1,810,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Trupanion employs 738 workers across the globe.

What is Trupanion's official website?

The official website for Trupanion is www.trupanion.com.

How can I contact Trupanion?

Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at 855-727-9079 or via email at [email protected]

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.